Drug Shortage Report for TARO-WARFARIN
| Report ID | 110915 |
| Drug Identification Number | 02242682 |
| Brand name | TARO-WARFARIN |
| Common or Proper name | WARFARIN |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | WARFARIN SODIUM |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 250 |
| ATC code | B01AA |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-03 |
| Estimated end date | 2020-04-24 |
| Actual end date | 2020-04-29 |
| Shortage status | Resolved |
| Updated date | 2020-05-01 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.